| Active, not recruiting | 4 | 93 | US | Radiation therapy, External beam radiation therapy, Intensity modulated radiation therapy, Proton therapy, Brachytherapy, Stereotactic body radiotherapy, Leuprolide, Leuprolide acetate, Lupron, Relugolix, Orgovyx, TAK-385 | Emory University, National Cancer Institute (NCI), Prostate Cancer Foundation | Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC V8, Stage II Prostate Cancer AJCC V8, Stage IIA Prostate Cancer AJCC V8, Stage IIB Prostate Cancer AJCC V8, Stage IIC Prostate Cancer AJCC V8, Stage III Prostate Cancer AJCC V8, Stage IIIA Prostate Cancer AJCC V8, Stage IIIB Prostate Cancer AJCC V8, Stage IIIC Prostate Cancer AJCC V8 | 03/25 | 03/25 | | |
| Not yet recruiting | 3 | 72 | US | Abiraterone Acetate, BR9004, BR9004-1, CB 7630, CB-7630, CB7630, JNJ-212082, Yonsa, Zytiga, Bicalutamide, Casodex, Cassotide, Cosudex, ICI 176,334, ICI 176334, Utamide, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography Angiography, CT ANGIOGRAPHY, CT Scan Angiography, CTA, Leuprolide, Leuprorelin, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Relugolix, N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea, Orgovyx, Relumina, TAK 385, TAK-385, TAK385 | Emory University, Pfizer, Sumitomo Pharma America, Inc., National Comprehensive Cancer Network, National Cancer Institute (NCI) | Recurrent Prostate Carcinoma, Stage III Prostate Cancer AJCC V8, Stage IVA Prostate Cancer AJCC V8 | 07/29 | 07/29 | | |
